Home » Topics » Neurology/psychiatric, BioWorld Science

Neurology/psychiatric, BioWorld Science
RSS

New analgesic agents reported in patent literature

Dec. 12, 2005

NDA filed for NRP-104 in ADHD

Dec. 12, 2005

Xyrem launched in Germany for cataplexy in adult with narcolepsy

Dec. 12, 2005

First milestone in Evotec and Takeda's Alzheimer's collaboration

Dec. 12, 2005

Neuren raises funding to advance neurological compounds

Dec. 9, 2005

Senexis and Galapagos expand collaboration

Dec. 9, 2005

ACP-103 reduces haloperidol-induced akathisia in patients with schizophrenia

Dec. 7, 2005

Private equity financing to support NeurogesX' development of Transacin

Dec. 7, 2005

Alza modifies U.S. clinical development program for OROS Hydromorphone

Dec. 7, 2005

Targeting mGluR1 for epilepsy

Dec. 7, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 12, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026